This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

  1. Resource
  2. Source: Campus Sanofi
  3. 15 May 2024

Praluent® (alirocumab) - Comprehensive Support for the Praluent® Patient

Author: Sanofi

Editorial Team

Praluent logo

Prescribing Information(GB)

Prescribing Information(NI)

Disclaimer: The resources contained within this section are updated regularly by Sanofi. Before you use any of the resources, or provide any resources to your patients please re-visit this page to ensure that you are using the most up-to-date version(s).

Patient Resources

Praluent®

Find more information on Indication, Administration and Mechanism of Action and watch videos about Praluent®.

Patient Website

Find resources and support for your patients on Praluent®. Find useful links about how patients can manage their cholesterol.

RESOURCES FOR PRALUENT® 75MG OR 150MG

▶ Living with High Cholesterol (PDF)

▶ Praluent® Injection Guide (PDF)

1/2

▶ Living with High Cholesterol (PDF)

▶ Praluent® Injection Guide (PDF)

▶ How to Inject Praluent® (video)

RESOURCES FOR PRALUENT® 300MG

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

1/2

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

▶ How to Inject Praluent® (video)

Links of interest

Website: MyPraluent® - This website was developed and funded by Sanofi

Patient Information Leaflet 75mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information leaflet 300mg (sourced from Medicines.org.uk)

1/5

Website: MyPraluent® - This website was developed and funded by Sanofi

Patient Information Leaflet 75mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information Leaflet 150mg (sourced from Medicines.org.uk)

Patient Information leaflet 300mg (sourced from Medicines.org.uk)

1/2

Patient Profiles

Homecare

Read the patients profiles you are likely to encounter in your practice who could be eligible for Praluent®.

Homecare is run by experienced pharmacists who dispense Praluent® and arrange delivery to patients.

SEE MORE FROM SCIENCE

Get in touch with the Dyslipidaemia Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023
References
  1. Schwartz G, et al. N Engl J Med 2018;379(22):2097–2107.

MAT-XU-2204602 (v9.0) Date of Preparation: May 2025